Drug profile · INN
naloxone
NALOXONE HYDROCHLORIDE (DBL)
naloxone (NALOXONE HYDROCHLORIDE (DBL)) is a opioid receptors; mu/kappa/delta antagonist. Associated with Pfizer Australia Pty Ltd.
Drug details — naloxone
- Class
- Various (V03)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
naloxone (NALOXONE HYDROCHLORIDE (DBL)) is a opioid receptors; mu/kappa/delta antagonist. Associated with Pfizer Australia Pty Ltd.
Key facts
Mechanism of action
Opioid receptors; mu/kappa/delta antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Recent coverage
FDA approves OTC Rextovy, broadening naloxone access for opioid overdose
FDA approved Rextovy, an over-the-counter 4 mg naloxone hydrochloride nasal spray for emergency opioid overdose treatment. Consumers can buy it without a prescription at pharmacies, convenience stores, and online, broadening public access to overdose reversal.
FDA Approves First OTC Naloxone Nasal Spray for Opioid Overdose
In a groundbreaking move, the FDA has approved the first over-the-counter naloxone nasal spray, providing a critical tool in combating opioid overdose emergencies.
Related & competitor drugs
Frequently asked questions
What is naloxone?
naloxone (NALOXONE HYDROCHLORIDE (DBL)) is a opioid receptors; mu/kappa/delta antagonist. Associated with Pfizer Australia Pty Ltd.
What is the brand name for naloxone?
NALOXONE HYDROCHLORIDE (DBL) is a marketed brand name for naloxone. Check FDA Drugs@FDA for the current US label holder and prescribing information.